Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Broad swathe of measures to support UK life sciences draws widespread applause

This article was originally published in Scrip

Executive Summary

Broad approval has been expressed by industry to the UK government's newly unveiled strategy to boost the UK life sciences sector, along with a review of innovation in the National Health Service. Prime Minister David Cameron gave a speech underlining the importance of the industry, which employs over 160,000 people in more than 4,000 firms, generating total annual turnover of some £50 billion. The country's four main life science trade bodies, united under the banner LifeSciencesUK, welcomed the new initiatives, saying they would "stimulate interest and investment in the UK life sciences sector".

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC015442

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel